MOTTA, MARCELLA
MOTTA, MARCELLA
DIPARTIMENTO DI ENDOCRINOLOGIA, FISIOPATOLOGIA E BIOLOGIA APPLICATA (attivo dal 01/01/2009 al 26/04/2012)
"Ultrashort" control of hypothalamic hormones secretion : a brief history
2004 F. Piva, M. Zanisi, M. Motta, L. Martini
5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3
1999 P. Negri-Cesi, A. Colciago, A. Poletti, M. Motta
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells : Crucial role of 5-lipoxygenase
2004 R.M. Moretti, M. Montagnani Marelli, A. Sala, M. Motta, P. Limonta
Activation of the orphan nuclear receptor RORα induces growth arrest in androgen-independent DU 145 prostate cancer cells
2001 R.M. Moretti, M. Montagnani Marelli, M. Motta, D. Polizzi, S. Monestiroli, G. Pratesi, P. Limonta
Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells
2006 M. Ruscica, E. Dozio, S. Boghossian, G. Bovo, V. M. Riano, M. Motta, P. Magni
Aging and the hypothalamic-pituitary complex of the male rat
1986 F. Piva, M. Zanisi, E. Messi, R. Maggi, F. Celotti, P. Negri-Cesi, M. Motta, L. Martini
Aging and the hypothalamo-pituitary-testicular axis in the rat
1987 F. Piva, P. Limonta, R. Maggi, D. Dondi, E. Messi, M. Zanisi, M. Motta
Aldosterone receptor antagonists: biology and novel therapeutic applications
2005 P. Magni, M. Motta
Aldosterone receptor antagonists: biology and novel therapeutical applications
2003 P. Magni, M. Motta
Altered peripheral myelination in mice lacking GABAB receptors
2008 V. Magnaghi, M. Ballabio, F. Camozzi, M. Colleoni, A. Consoli, M. Gassmann, G. Lauria, M. Motta, P. Procacci, A.E. Trovato, B. Bettler
Androgen metabolism in different target tissues
1990 L. Martini, F. Celotti, M.J. Lechuga, R.C. Melcangi, M. Motta, P. Negri-Cesi, A. Poletti, S. Zoppi
Androgen metabolism in the human prostatic cancer cell line LNCaP
1994 P. Negri-Cesi, M. Motta
Androgen metabolism in the prostate: effect of antihormonal agents
1989 P. Negri-Cesi, S. Zoppi, M. Motta
Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH
1994 P. Limonta, R.M. Moretti, D. Dondi, M. Montagnani Marelli, M. Motta
Antiproliferative action of melatonin on human prostate cancer LNCaP cells
2000 R.M. Moretti, M. Montagnani Marelli, R. Maggi, D. Dondi, M. Motta, P. Limonta
Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop
1994 D. Dondi, P. Limonta, R. M. Moretti, M. Montagnani Marelli, E. Garattini, M. Motta
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP
1992 P. Limonta, D. Dondi, R.M. Moretti, R. Maggi, M. Motta
Antitumor effects of carnertinib in castration resistant prostate cancer models : a comparative study with erlotinib
2011 G.L. Gravina, F. Marampon, M. Piccolella, L. Biordi, C. Ficorella, M. Motta, E.A. Jannini, V. Tombolini, C. Festuccia
Benign prostatic hyperplasia and steroid metabolism: effects of enzyme inhibitors
1991 M. Motta, P. Negri-Cesi, S. Zoppi
Cellular mechanisms regulating uPA in hormone refractory prostate cancer : role of suPAR, a solubile form of Urokinase Plasminogen-Activator Receptor
2007 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi